Neogen Stock

Neogen P/E

The (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. of Neogen (NEOG) as of Jun 23, 2026 is -2.18.In the previous year, (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. was -252.6 — a change of -99.14% (higher).

P/E

-2.18

YoY

-99.14%

Last updated:

As of Jun 23, 2026, Neogen's P/E ratio was -2.18, a -99.14% change from the -252.6 P/E ratio recorded in the previous year.

The Neogen P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/E
Date
P/E
Jan 1, 2006
2,682 base
Jan 1, 2007
4,134 base
Jan 1, 2008
3,097 base
Jan 1, 2009
3,835 base
Jan 1, 2010
5,417 base
Jan 1, 2011
3,199 base
Jan 1, 2012
4,840 base
Jan 1, 2013
6,132 base
Jan 1, 2014
6,556 base
Jan 1, 2015
6,322 base
Jan 1, 2016
6,832 base
Jan 1, 2017
7,202 base
Jan 1, 2018
4,711 base
Jan 1, 2019
5,686 base
Jan 1, 2020
7,044 base
YEARP/E
2026 est 30,21
2025 -1,39
2024 -278,96
2023 -165,89
2022 34,05
2021 79,86
2020 70,44
2019 56,86
2018 47,11
2017 72,02
2016 68,32
2015 63,22
2014 65,56
2013 61,32
2012 48,40
2011 31,99
2010 54,17
2009 38,35
2008 30,97
2007 41,34
2006 26,82
Access this data via the Eulerpool API
Get Free API Key

Neogen Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Neogen's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Neogen's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Neogen's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Neogen grows earnings faster than its peers.

Neogen Stock analysis

What does Neogen do? Neogen Corp is a leading provider of food safety and animal health solutions based in Lansing, Michigan, USA. The company was founded in 1982 by James Herbert and initially focused on the development and manufacturing of rapid tests for the dairy industry. Since then, Neogen has become an internationally operating company with over 25 subsidiaries and 1,800 employees. Neogen's business model is based on providing solutions for safe and healthy food supply and animal husbandry. The company operates in two main divisions: Food Safety and Animal Safety. Within these divisions, Neogen offers a wide range of test kits, diagnostic tools, information management software, and other products that help minimize the risk of food poisoning and improve the health of livestock. In the Food Safety division, Neogen offers a variety of test kits that allow food producers and retailers to quickly and easily detect various types of contaminants in food. These include tests for salmonella, E. coli, listeria, and mycotoxins. The company also provides tools for monitoring water quality and verifying cleaning and disinfection processes in food processing plants. In the Animal Safety division, Neogen also offers an extensive range of diagnostic tools to improve the health of livestock. The tests include infectious diseases such as brucellosis, BSE (mad cow disease), mastitis, and leukemia. Additionally, Neogen provides tools for animal identification and animal health data management. Neogen has also specialized in the development of technologies to improve animal health and nutrition, such as probiotics and supplements for livestock. Another focus of Neogen is the development of information management software that enables food producers and retailers to streamline the process of food safety and quality. The software allows companies to track tests, analyze data, and implement best practices to minimize the risk of food poisoning. In recent years, Neogen has also increasingly focused on the global market, especially the Asian market. The company has subsidiaries in various parts of the world, including Europe, Latin America, and Asia. Neogen works closely with local regulatory authorities to offer its products in accordance with local requirements. In conclusion, Neogen Corp is a leading provider of food safety and animal health solutions, focusing on the development and manufacturing of test kits, diagnostic tools, and information management software. The company has experienced impressive growth in recent decades and is now operating internationally. With its commitment to safe and healthy food supply and animal husbandry, Neogen sets industry standards. Neogen is one of the most popular companies on Eulerpool.

P/E Details

Deciphering Neogen's P/E Ratio

The Price to Earnings (P/E) Ratio of Neogen is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Neogen's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Neogen is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Neogen’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Neogen stock

(Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. of Neogen amounted to -252.6 -2.18

The P/E ratio in evaluating a stock.

The price-earnings ratio (P/E ratio) is an important financial ratio that is often used by investors to assess the attractiveness of a stock. It is an indicator of a company's earnings and valuation, and provides an indication of whether a stock is overvalued or undervalued. It is also used as an indicator of whether a stock is "expensive" or "cheap".

History of P/E ratio

The P/E ratio was first used in 1881 by the famous financial scientist Benjamin Graham. He developed the P/E ratio as a means to evaluate whether a stock is trading at a "good" or "bad" price. Since then, the P/E ratio has had a long history in the financial world, particularly among investors who are looking for a way to evaluate stocks in an informed manner.

Calculation of the P/E ratio

The P/E ratio is calculated by dividing the current stock price by the earnings per share. A simple formula for calculating the P/E ratio is as follows:

P/E ratio = Stock price / Earnings per share

Example: If a stock is traded at the current price of $10 and the earnings per share is $1, the P/E ratio would be 10 ($10 / $1 = 10).

Application of the P/E ratio

Investors use the P/E ratio to assess the attractiveness of a stock. A high P/E ratio can indicate that a stock is overvalued, while a low P/E ratio means that a stock is undervalued. Investors can then decide whether to buy, sell, or hold a stock based on this information. Another reason why investors use the P/E ratio is to check how stocks perform compared to other stocks or the market as a whole. If a stock's P/E ratio is higher than the overall market's P/E ratio, this may mean that the stock is overvalued, and investors can decide whether to sell or hold the stock. Investors usually also use the P/E ratio to compare stocks over time. If a stock has a P/E ratio of 10 and a year later has a P/E ratio of 20, this may mean that the stock is overvalued. Investors can then decide whether to hold or sell the stock.

Advantages and Disadvantages of using the P/E ratio

BenefitsThe P/E ratio is a useful tool to assess the attractiveness of a stock and to evaluate how a stock is performing compared to the market. It is a simple tool that can assist investors in deciding whether to buy, sell, or hold a stock.

DisadvantagesThe P/E ratio is a simple tool that does not provide any information about the future performance of a stock. It can be difficult to predict the future performance of a stock, and sometimes the P/E ratio can give a false picture of a stock. Therefore, investors must be cautious when relying on the P/E ratio.

In addition, the P/E ratio can vary depending on the industry, which makes comparability difficult. For example, a stock in a certain industry may have a low P/E ratio, while another stock in a different industry may have a higher P/E ratio. Therefore, investors must be cautious when relying on the P/E ratio.

Conclusion

The P/E ratio is a useful tool that can assist investors in assessing the attractiveness and value of a stock. It can also be used to check how a stock is performing in comparison to the market. However, it is important to note that it is a simple tool that does not make any statement about the future performance of a stock, and investors must be cautious when relying on the P/E ratio.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Neogen

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Neogen